Mr. Shaun Flanagan:

There was one meeting. It must be remembered that these were not conventional negotiations. There is a monopoly on the other side. There is no trade off. We are either reimbursing or not reimbursing. We do not have a trade off in the form of a conventional negotiation. We met the company and prepared for that meeting. In that particular case we had a health technology assessment, HTA, report. We provided the company with our view on what the best chance for the medicine getting through the process was and pointers around where we felt they could improve their offer.

It is then up to the company to decide whether it is in a position to do so. We met and we got a formal written offer.